Vanta Bioscience Ltd. Stock Analysis 540729.BO

Vanta Bioscience Ltd. engages in the full service preclinical contract research organization. The firm provides services for testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. The company offers a host of preclinical safety assessment services for clients from pharmaceuticals, medical devices, nutraceuticals, feed additives, biotech, agrochemicals, cosmetics, and chemical industries. Additionally, it provides risk assessment services to evaluate the safety of active pharmaceutical ingredients, excipients, extractables, leachable, and pharmaceutical impurities resulting from the manufacturing process or product degradation. The Company’s services include discovery toxicology, agro-chemical and chemical safety, biocompatibility studies, diet formulation, and batch release tests. The firm has investments in one of its subsidiaries, Vantaclinical Research Limited.